Comparison of Picosecond Pulsed Nd:YAG Laser and Fractional Laser for the Treatment of Acne Scars

Acne Scars Clinical Trial

Official title:

Comparison of Picosecond Pulsed Nd:YAG Laser and Fractional Laser for the Treatment of Acne Scars

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03850925
• Other study ID #: 2019_02_004
• Status: Recruiting
• Phase: N/A
• Start date: May 1, 2019
• Est. completion date: April 30, 2020

Study information

• Verified date: April 2019
• Source: Dongtan Sacred Heart Hospital
• Contact: Gyeong-Hun Park, MD, PhD
• Phone: +82-31-8086-2839
• Email: parkgh[@]hallym.or.kr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study compares the application of a picosecond 1064-nm laser with a diffractive lens array with nonablative fractional laser for the treatment of acne scarring.

Description:

This trial is a 17-week, prospective, randomized split-face study that compares the results between two facial sides either receiving the picosecond 1064-nm laser or nonablative fractional laser treatment for atrophic acne scar.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 25
• Est. completion date: April 30, 2020
• Est. primary completion date: April 30, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 19 Years and older

Eligibility

Inclusion Criteria:

• Subjects with facial atrophic acne scars

• Subjects who observe the schedules and protocols of the clinical trial

• Subjects who give informed consent to participate in the clinical trial

Exclusion Criteria:

• Subjects who have active acne under treatment

• Subjects who had received any other treatments for acne scarring for 6 months prior to the first treatment

• Subjects who underwent other treatments including chemical, mechanical or laser resurfacing during the study period

• Subjects who have current acute illness

• Subjects who are considered inappropriate for the clinical trial under the judgement of investigators

Related Conditions & MeSH terms

• Acne Scars

Intervention

Procedure:
• Laser therapy
4 consecutive sessions of laser therapy

Locations

Country	Name	City	State
Korea, Republic of	Dongtan Sacred Heart Hospital, Hallym Universtiy College of Medicine	Hwaseong-si	Gyeonggi-do

Sponsors (1)

Lead Sponsor	Collaborator
Dongtan Sacred Heart Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in the mean of the ECCA grading scale	The ECCA (échelle d'évaluation clinique des cicatrices d'acné) grading scale: minimum score 0; maximum score 270; higher values represent a worse outcome.	Week 17